Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Ironwood Pharmaceuticals Inc’s stock clocked out at $8.10, down -2.53% from its previous closing price of $8.31. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 1.85 million shares were traded. IRWD stock price reached its highest trading level at $8.355 during the session, while it also had its lowest trading level at $8.09.
Ratios:
To gain a deeper understanding of IRWD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.92. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 0.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on January 17, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On December 14, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.
On November 09, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $21.Jefferies initiated its Buy rating on November 09, 2023, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Duane Jon R bought 6,920 shares for $8.70 per share. The transaction valued at 60,204 led to the insider holds 121,028 shares of the business.
Emany Sravan Kumar bought 10,684 shares of IRWD for $100,216 on Mar 04 ’24. The SVP, Chief Financial Officer now owns 301,733 shares after completing the transaction at $9.38 per share. On Feb 12 ’24, another insider, MCCOURT Thomas A, who serves as the Chief Executive Officer of the company, sold 177,164 shares for $15.24 each. As a result, the insider received 2,699,979 and left with 832,774 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 1300754816 and an Enterprise Value of 1891266048. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86. Its current Enterprise Value per Revenue stands at 4.272 whereas that against EBITDA is 11.131.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $15.70, while it has fallen to a 52-week low of $7.53. The 50-Day Moving Average of the stock is -19.54%, while the 200-Day Moving Average is calculated to be -21.97%.
Shares Statistics:
It appears that IRWD traded 4.59M shares on average per day over the past three months and 2579320 shares per day over the past ten days. A total of 156.35M shares are outstanding, with a floating share count of 151.60M. Insiders hold about 3.15% of the company’s shares, while institutions hold 107.50% stake in the company. Shares short for IRWD as of 1711584000 were 21954392 with a Short Ratio of 4.78, compared to 1709164800 on 15511416. Therefore, it implies a Short% of Shares Outstanding of 21954392 and a Short% of Float of 22.850001.
